MediStem Laboratories, Inc. To Hold Investor Conference Call To Discuss First Clinic Licensed To Deliver Company’s Proprietary Stem Cell Treatments; CEO To Outline Progress To License Stem Cell Technology To Additional Clinics And Laboratories Worldwide

Medistem Laboratories, Inc. (OTCBB:MDSM) (FWB:S2U), committed to the ethical development of next-generation medical therapies from non-controversial adult stem cell sources, will hold an investor conference call on Monday, August 14, 2006, at Noon Eastern to review recent business milestones and events, including the licensing of the Company’s first affiliated clinic and stem cell bank.